ST6GAL1 and malignant colon neoplasm: To investigate the effects of ST6GAL1-mediated sialylation on EGFR activity, we assessed EGFR activation in pancreatic, ovarian, and colon cancer cell lines in which ST6GAL1 expression was directly modulated.